PI

Impinj, Inc.
$144.03
-0.37 (-0.26%)
Mkt Cap 4.39B
Volume 156,008
52W Range 87.36-247.064
Sector Technology
Beta 1.93
EPS (TTM) -0.91
P/E Ratio -470.30
Revenue (TTM) 361.05M
Rev Growth (5Y) +21.1%
EPS Growth (5Y) N/A
AlphaVal · Fair Value
What we estimate one share is worth
$45.90
Overvalued strong signal
213.8% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade · Gated
How strong & durable the business is
F
Platform & Compounding FCF
30.0 / 100 pillar composite (overridden)
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 361.07M 366.09M 307.54M 257.80M 190.28M 138.92M 152.84M 122.63M 125.30M 112.29M 78.48M 63.76M
Net Income (10.85M) 40.84M (43.37M) (24.30M) (51.26M) (51.92M) (22.99M) (35.23M) (17.32M) (1.67M) 900,000 297,000
EPS -0.37 1.46 -1.62 -0.95 -2.12 -2.28 -1.05 -1.65 -0.84 -0.08 -0.81 -0.86
Free Cash Flow 45.88M 111.20M (68.22M) (11.44M) (9.77M) (19.95M) 2.28M (18.14M) (42.44M) (13.03M) (3.99M) (1.85M)
FCF / Share 1.57 3.98 -2.55 -0.45 -0.40 -0.87 0.10 -0.85 -2.05 -0.66 -0.31 -0.14
Operating CF 58.75M 128.31M (49.38M) 640,999 6.46M (16.88M) 4.71M (11.78M) (35.89M) (9.50M) 3.46M (832,000)
Total Assets 545.19M 489.08M 359.41M 349.74M 315.54M 207.62M 215.05M 145.07M 152.03M 167.54M 52.85M 33.82M
Total Debt 326.73M 298.52M 294.59M 294.43M 308.51M 73.46M 73.52M 24.93M 11.27M 15.09M 19.63M 9.61M
Cash & Equiv 48.21M 46.05M 94.79M 19.60M 123.90M 23.64M 66.90M 17.53M 19.29M 33.64M 10.12M 6.94M
Book Value 209.23M 149.86M 34.13M 15.59M (11.08M) 109.12M 125.24M 97.88M 118.94M 124.02M 12.93M 10.19M
Return on Equity -0.05 0.27 -1.27 -1.56 N/A -0.48 -0.18 -0.36 -0.15 -0.01 0.07 0.03
PI News
Impinj to Announce Second-Quarter 2026 Financial Results
Jul 06, 2026 12:15 PM · businesswire.com
Director Sells 33,000 Impinj Shares Worth $4.6 Million
Jun 30, 2026 02:44 AM · fool.com
Director Sells 45,000 Impinj Shares Worth $6.4 Million
Jun 27, 2026 05:36 AM · fool.com
Intel vs. Impinj: Which Technology Stock Is a Better Buy in 2026?
Jun 18, 2026 02:30 AM · fool.com
Insiders Are Selling These 3 Stocks—Should Investors Be Concerned?
Jun 17, 2026 08:55 AM · marketbeat.com
New TALVEY® (talquetamab-tgvs) plus DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj) data demonstrate the strength of a bispecific combination in earlier-line relapsed or refractory multiple myel
Jun 13, 2026 03:00 AM · gurufocus.com
Large Impinj Investor Trims Position by $11.3 Million
Jun 05, 2026 12:11 PM · fool.com
Imagion Biosystems' IND Application for MagSense® Phase 2 Clinical Trial Clears FDA Review
Jun 02, 2026 08:00 AM · gurufocus.com
Impinj (PI) Just Reclaimed the 200-Day Moving Average
May 27, 2026 06:30 AM · zacks.com
Impinj to Participate in Evercore Global TMT Conference
May 26, 2026 12:15 PM · businesswire.com